Surgery has long been the gold standard for diagnosis and management of early-stage operable lung cancer. For patients with inoperable disease or more extensive disease, however, alternative approaches are emerging. […] Read more
Transbronchial Microwave Ablation of Malignant Lung Nodules: Outcomes, Challenges, and Perspective
+more
With increasing availability of CT scans and strong evidence for the utility of low-dose CT screening in high-risk populations,1 an increasing number of small lung nodules are being incidentally discovered. […] Read more
Curative therapy remains elusive in early-stage NSCLC following surgical resection, sometimes even for patients with stage I disease. Adjuvant therapy can be of benefit, but only for a select few. As shown in the Lung Adjuvant […] Read more
By Tetsuya Mitsudomi, MD Posted: April 16, 2020 The general principle of surgery for cancer of any organ is to remove the entire tumor with adequate margins of normal tissue […] Read more
By Kara Nyberg, PhD Posted: April 16, 2020 After decades of failed clinical trials and persistently dismal lung cancer survival outcomes, the 2010s breathed new life into the beleaguered field […] Read more
By Jessica Donington, MD, MSCR Posted: November 12, 2019 Dr. Jessica Donington Approximately 80% to 85% of patients undergoing lung cancer resections have a smoking history, and 20% are active smokers. […] Read more